National Historical Income Statement
| NHI Stock | USD 77.71 0.16 0.21% |
Historical analysis of National Health income statement accounts such as Gross Profit of 169 M can show how well National Health Investors performed in making a profits. Evaluating National Health income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of National Health's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining National Health Investors latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether National Health Investors is a good buy for the upcoming year.
National |
About National Income Statement Analysis
National Health Investors Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to National Health shareholders. The income statement also shows National investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
National Health Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts National Health Investors generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of National Health Investors minus its cost of goods sold. It is profit before National Health operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of National Health Investors. It is also known as National Health overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Operating Income
Operating Income is the amount of profit realized from National Health Investors operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of National Health Investors is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Most accounts from National Health's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into National Health Investors current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in National Health Investors. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. As of now, National Health's Selling General Administrative is increasing as compared to previous years. The National Health's current Net Income Applicable To Common Shares is estimated to increase to about 102.4 M, while Depreciation And Amortization is projected to decrease to under 36.5 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 287.1M | 268.4M | 308.3M | 169.0M | Total Revenue | 298.7M | 278.2M | 319.8M | 170.8M |
National Health income statement Correlations
Click cells to compare fundamentals
National Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
National Health income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 76.8M | 106.6M | 165.4M | 140.0M | 70.0M | 36.5M | |
| Interest Expense | 56.3M | 52.9M | 50.8M | 44.9M | 55.5M | 58.3M | |
| Total Revenue | 318.1M | 332.8M | 298.7M | 278.2M | 319.8M | 170.8M | |
| Gross Profit | 312.3M | 323.2M | 287.1M | 268.4M | 308.3M | 169.0M | |
| Other Operating Expenses | 98.1M | 108.9M | 165.3M | 135.0M | 141.0M | 73.1M | |
| Operating Income | 220.0M | 220.8M | 132.2M | 81.1M | 178.8M | 96.8M | |
| Ebit | 220.0M | 197.3M | 47.5M | 12.0M | 179.0M | 188.0M | |
| Ebitda | 296.8M | 304.0M | 213.0M | 152.0M | 249.0M | 125.4M | |
| Total Operating Expenses | 92.3M | 99.2M | 153.7M | 125.2M | 129.5M | 69.1M | |
| Net Income | 104.2M | 135.4M | 62.2M | 23.1M | 135.7M | 80.8M | |
| Income Tax Expense | 56.3M | 49.9M | 49.8M | 42.4M | 55.1M | 57.8M | |
| Selling General Administrative | 13.9M | 14.6M | 19.3M | 25.3M | 19.7M | 20.7M | |
| Cost Of Revenue | 5.8M | 9.7M | 11.6M | 9.8M | 11.5M | 10.9M | |
| Income Before Tax | 160.4M | 185.3M | 112.0M | 65.5M | 134.4M | 104.3M | |
| Net Income Applicable To Common Shares | 160.5M | 185.1M | 111.8M | 66.4M | 76.4M | 102.4M | |
| Total Other Income Expense Net | (59.6M) | (33.5M) | (15.0M) | (80.2M) | (44.4M) | (42.2M) | |
| Net Income From Continuing Ops | 160.4M | 185.3M | 112.0M | 65.1M | 134.4M | 127.7M | |
| Interest Income | 791K | 18.2M | 1.5M | 569K | 512.1K | 486.5K | |
| Net Interest Income | (56.3M) | (52.9M) | (50.8M) | (44.9M) | (58.2M) | (61.1M) | |
| Reconciled Depreciation | 76.8M | 83.2M | 80.8M | 70.9M | 70.0M | 60.6M |
Currently Active Assets on Macroaxis
When determining whether National Health Investors offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of National Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of National Health Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on National Health Investors Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in National Health Investors. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National Health. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.14) | Dividend Share 3.6 | Earnings Share 2.91 | Revenue Per Share 7.598 | Quarterly Revenue Growth (0.12) |
The market value of National Health Investors is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National Health's value that differs from its market value or its book value, called intrinsic value, which is National Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National Health's market value can be influenced by many factors that don't directly affect National Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between National Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if National Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.